CPS-118 - Valproate-containing medicines and additional risk minimization measures: Knowledge and attitudes of the community pharmacist

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: CPS-118
• By: ALMEIDA, Maria Teresa (Board of National Association of Pharmacies, Portugal (ANF) , Portugal)
• Co-author(s): João Pereira (Faculty of Sciences and Technology, University of Algarve (FCT, UAlg), Faro, Portugal)
  Mrs Maria Teresa Almeida (Board of National Association of Pharmacies, Portugal (ANF) , Lisboa, Portugal)
  Teresa Almeida (Board of National Association of Pharmacies, Portugal (ANF) , Lisboa, Portugal)
  Carolina Rojais (Centre for Health Evaluation & Research/Infosaúde, National Association of Pharmacies (CEFAR/IF, ANF), Lisboa, Portugal)
  Catarina Nunes (Centre for Medicines Information and Health Interventions/Infosaúde, National Association of Pharmacies (CEDIME/IF, ANF) , Lisboa, Portugal)
  Isabel Ramalhinho (Faculty of Sciences and Technology, University of Algarve (FCT, UAlg), Faro, Portugal / Algarve Biomedical Center Research Institute, University of Algarve (ABC-Ri, UAlg), Faro, Portugal)
  
• Abstract:

  Introduction
  Background
  Risk minimization measures (RMM) are interventions that aim preventing or reducing adverse reactions associated with medication use, as well as to mitigate their severity and overall impact. Routine RMMs apply to all medications that receive Marketing Authorization (MA), whereas additional RMMs are only implemented when..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login